M

Magellan Health Inc
F:MAH1

Watchlist Manager
Magellan Health Inc
F:MAH1
Watchlist
Price: 83.5 EUR
Market Cap: €2.2B

P/B

1.3
Current
7%
More Expensive
vs 3-y average of 1.2

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.3
=
Market Cap
€2.2B
/
Total Equity
$1.9B

Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.

P/B
1.3
=
Market Cap
€2.2B
/
Total Equity
$1.9B

Valuation Scenarios

Magellan Health Inc is trading above its 3-year average

If P/B returns to its 3-Year Average (1.2), the stock would be worth €78.22 (6% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-6%
Maximum Upside
+137%
Average Upside
54%
Scenario P/B Value Implied Price Upside/Downside
Current Multiple 1.3 €83.5
0%
3-Year Average 1.2 €78.22
-6%
5-Year Average 1.2 €78.97
-5%
Industry Average 3.1 €197.49
+137%
Country Average 2.5 €159.03
+90%

Forward P/B
Today’s price vs future total equity

Not enough data available to calculate forward P/B

Peer Comparison

All Multiples
P/B
P/E
All Countries
Close
Market Cap P/B P/E
US
Magellan Health Inc
F:MAH1
2.2B EUR 1.3 8.5
US
UnitedHealth Group Inc
NYSE:UNH
321.9B USD 3.1 26.7
US
Anthem Inc
LSE:0HG8
91.5B USD 2.1 17.3
US
Elevance Health Inc
NYSE:ELV
77.4B USD 1.8 14.8
US
Humana Inc
NYSE:HUM
27B USD 1.5 22.7
US
Centene Corp
NYSE:CNC
21.4B USD 1.1 -3.2
US
Molina Healthcare Inc
NYSE:MOH
9.3B USD 2.3 49.6
US
Healthequity Inc
NASDAQ:HQY
7.1B USD 3.4 33
BR
Odontoprev SA
BOVESPA:ODPV3
8.1B BRL 6.3 13.8
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 2.9 25.7
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
6.7B BRL 0.1 -47.2
P/E Multiple
Earnings Growth PEG
US
M
Magellan Health Inc
F:MAH1
Average P/E: 23.6
8.5
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26.7
22%
1.2
US
A
Anthem Inc
LSE:0HG8
17.3
10%
1.7
US
Elevance Health Inc
NYSE:ELV
14.8
10%
1.5
US
Humana Inc
NYSE:HUM
22.7
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -3.2 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
49.6
14%
3.5
US
Healthequity Inc
NASDAQ:HQY
33
32%
1
BR
Odontoprev SA
BOVESPA:ODPV3
13.8
4%
3.4
US
Progyny Inc
NASDAQ:PGNY
25.7
35%
0.7
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -47.2 N/A N/A

Market Distribution

Lower than 75% of companies in the United States of America
Percentile
25th
Based on 10 946 companies
25th percentile
1.3
Low
0 — 1.5
Typical Range
1.5 — 4.8
High
4.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 1.5
Median 2.5
70th Percentile 4.8
Max 147 580.5

Magellan Health Inc
Glance View

Market Cap
2.2B EUR
Industry
Health Care

In the world of healthcare innovation, Magellan Health Inc. has carved a notable niche, presenting a fresh compass in navigating complex healthcare systems. Founded with a keen focus on specialized management in the healthcare industry, Magellan Health has grown into a formidable player by providing comprehensive solutions in behavioral health, specialty healthcare, and pharmacy management. The company's journey is centered around bridging gaps within the healthcare system, offering services that address mental health and substance abuse issues, emphasizing its commitment to fostering holistic well-being. By managing these critical areas, Magellan partners with payers, providers, and public sector agencies, effectively orchestrating a network that alleviates the burden of mental health challenges and optimizes patient outcomes across the board. At its core, Magellan's financial engine hums through its innovative integration of managed care programs and technology-driven solutions. It generates revenue by offering tailored solutions that help reduce costs while improving access and outcomes. Through a mix of managed care plans for specialty populations and cutting-edge digital platforms, Magellan enhances the delivery of healthcare services, ensuring they reach those who need them most. The company's business model thrives on performance-based contracts and management fees, where success is measured by its ability to improve health care quality and efficiency. By continuously investing in technology and analytics, Magellan Health not only advances its core mission but also sustains a robust economic model that remains resilient amid evolving health sector dynamics.

MAH1 Intrinsic Value
Not Available
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett